|
|
Volumn 19, Issue 6, 2002, Pages 405-412
|
|
Alfuzosin: a clinically uroselective alpha1-blocker.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFUZOSIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
QUINAZOLINE DERIVATIVE;
AGED;
ANIMAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
FOLLOW UP;
HUMAN;
MALE;
MICTURITION DISORDER;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PROSTATE;
PROSTATE HYPERTROPHY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADRENERGIC ALPHA-ANTAGONISTS;
AGED;
ANIMALS;
CLINICAL TRIALS, PHASE III;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATE;
PROSTATIC HYPERPLASIA;
QUINAZOLINES;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
URINATION DISORDERS;
|
|
EID: 0036547646
PISSN: 07244983
EISSN: None
Source Type: Journal
DOI: 10.1007/s00345-002-0244-9 Document Type: Review |
|
Times cited : (28)
|
|
References (0)
|
